Consensus on diagnosis and management of Hereditary Angioedema in the Middle East: A Delphi initiative.

"Declaration of competing interest All authors received honoraria from COGENCE HEALTH DWC LLC. COGENCE HEALTH received funding from Takeda Pharmaceutical Company Limited to facilitate this project. Prof. M Maurer declared, he received research funding from Alnylam, BioCryst, Centogene, CSL Behring, Kalvista, Pharming, Pharvaris, and Shire/Takeda as a speaker and/or an advisor. Dr. F Zaitoun declared, he is an Executive Board Member, Immediate Past President: PASAAI. Dr. M Al-Ahmad declared, she received advisory board and speaker fees from AstraZeneca, Sanofi, Novartis, and GlaxoSmithKline. Dr. W Al-Herz declared, he received honoraria from Takeda Pharmaceutical Company Limited. Dr. H Alrayes, Dr. M Abuzakouk, Dr. S Al-Tamemi, Dr. R Arnaout, Dr. H Binghadeer, Dr. R Gutta, Dr. C Irani, Dr. H Mobayed, Dr. I Nasr, Dr. H Shendi have no additional competing interest to declare."